Search all medical codes

Peripheral T-cell lymphoma, not classified, lymph nodes of multiple sites

ICD10CM code

Name of the Condition

  • Peripheral T-cell lymphoma, not elsewhere classified, lymph nodes of multiple sites (ICD-10 Code: C84.48)

Summary

Peripheral T-cell lymphoma (PTCL) is a rare and aggressive group of non-Hodgkin lymphomas that originate from mature T-lymphocytes. When classified as "not elsewhere classified" and involving lymph nodes of multiple sites, the disease indicates a widespread presence and a complex treatment pathway.

Causes

The exact cause of PTCL is not well understood. However, it is believed to involve genetic mutations and alterations in DNA that affect T-cell production and regulation. Environmental factors and infections, such as the Epstein-Barr virus (EBV), may contribute to its development.

Risk Factors

  • Age: Most common in individuals over 60.
  • Ethnicity: Slightly higher prevalence in Asian populations.
  • Genetic predispositions or a family history of lymphoma.
  • Immunosuppression or a compromised immune system.
  • History of infections like EBV or HTLV-1.

Symptoms

  • Swollen lymph nodes.
  • Fever and night sweats.
  • Unexplained weight loss.
  • Fatigue and loss of appetite.
  • Skin rashes or itching.

Diagnosis

  • Physical examination and medical history.
  • Imaging tests such as PET or CT scans to detect spread.
  • Lymph node biopsy to analyze the type of lymphoma cells.
  • Blood tests to assess overall health and specific biomarkers.

Treatment Options

  • Chemotherapy is often the first-line treatment to target high proliferation of cancerous cells.
  • Radiation therapy may be used to reduce tumor size and alleviate symptoms.
  • Stem cell transplant may be considered in certain cases to restore healthy cells.
  • Targeted therapies and monoclonal antibodies to attack specific cancer cells.

Prognosis and Follow-Up

The prognosis for PTCL varies widely depending on several factors, including the cancer stage and patient health. Treatment response is generally poorer compared to B-cell lymphomas. Regular follow-up and monitoring are crucial to track treatment efficacy and detect recurrences early.

Complications

  • Potential spread to other organs or tissues.
  • Increased risk of infections due to compromised immunity.
  • Treatment side effects, such as organ toxicity or secondary cancers.

Lifestyle & Prevention

  • No guaranteed preventive measures exist.
  • Maintaining a healthy lifestyle with balanced nutrition and regular exercise may support overall wellness.
  • Awareness of early symptoms and timely medical assessment can aid in early diagnosis.

When to Seek Professional Help

Seek medical attention if experiencing persistent swelling of lymph nodes, unexplained fever, night sweats, significant weight loss, or prolonged fatigue.

Additional Resources

Tips for Medical Coders

  • Ensure accurate documentation of "not elsewhere classified" to prevent misclassification.
  • Verify that the diagnosis specifies multiple lymph node involvement.
  • Be aware of common overlaps and similarities with other lymphomas to avoid coding errors.

Medical Policies and Guidelines for Peripheral T-cell lymphoma, not classified, lymph nodes of multiple sites

Related policies from health plans

Beleodaq (belinostat)
Beleodaq (belinostat)
Istodax (romidepsin)

Similar Codes